TERRY DAVIS: Open Payments
NPI 1093737371 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,201 in 46 payments from 13 companies in 2025. Trend: 2023 $1,341 · 2024 $1,544 · 2025 $1,201
Food & beverage: $937Education: $264
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $376 |
| Janssen Biotech, Inc. | 5 | $211 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $188 |
| Amgen Inc. | 5 | $81 |
| Organon LLC | 4 | $67 |
| Arcutis Biotherapeutics, Inc. | 3 | $64 |
| Lilly USA, LLC | 2 | $52 |
| UCB, Inc. | 1 | $35 |
| Galderma Laboratories, L.P. | 1 | $33 |
| MERZ NORTH AMERICA, INC. | 1 | $24 |
Products named: SKYRIZI, TREMFYA, Otezla, ILUMYA, VTAMA, Zoryve, TALTZ, Bimzelx.
Industry payments across NV — which companies pay providers there.
